Tasigna Atherosclerosis Lawsuit News

NBA Star's Arterial Blockage May Have Been Caused by Taking Tasigna

Kareem Abdul Jabbar was required to undergo "quadruple coronary bypass surgery" despite being a vegan and living a healthy lifestyle. His only vice might have been using the anti-cancer drug Tasigna

Saturday, September 22, 2018 - There is no questioning how deadly and toxic anti-cancer chemotherapy drugs can be. Their purpose is to kill cancer cells and leave good cells unaffected. Chemotherapy drug Tasigna is so highly toxic that it is tremendously effective in defeating chronic myeloid leukemia (CML), a rare form of cancer. The issue in question is that the same high level of toxicity that helps Tasigna defeat cancer also causes atherosclerosis, the accumulation of fatty plaque within the body's major arteries. Tasigna patients elated to be cancer free may be faced with certain death from irreversible atherosclerosis. The linkage between Tasigna and atherosclerosis, however, can be overlooked. Here's a perfect example.

NBA Hall-of-Famer Kareem Abdul Jabbar has recently beaten cancer and is now enthusiastically singing the praises of anti-cancer chemotherapy drug Tasigna. A recent issue of People online magazine celebrated Kareem's 10-year anniversary of being cancer-free. Although Kareem's leukemia is at "microscopic levels," he must continue to take Tasigna for his entire life. The People online article fails to mention that in 2015, Kareem Jabbar, a well-conditioned athlete on a vegan diet, was forced to undergo quadruple coronary bypass surgery and that the cause of his heart disease is most likely the long-term use of the drug Tasigna.

As I said previously, Tasigna is so potent that it kills more than just the proteins that cancer cells need to increase. Tasigna's toxicity affects the inner walls of the arteries which are normally smooth and slippery, allowing the blood to flow freely. Tasigna irritates the artery's inner surface and causes plaque to stick to them. Plaque build-up over time narrows the passageway to the heart, brain, and extremities. Tasigna causes rapid-onset atherosclerosis, is irreversible and fatal.

The fact that Tasigna causes atherosclerosis is not in question. Novartis, the maker of Tasigna, has been forced by the US Food and Drug Administration (FDA) to update labels of Tasigna to reflect the risk of patients developing atherosclerosis. Tasigna carries a "black boxed" warning label, reserved for drugs with the potential to cause serious injuries and death. Physicians intent on administering Tasigna for the first time are required to perform an Electro Cardiogram (ECG) on potential Tasigna patients in order to screen out those with a pre-existing heart condition or blood abnormality. The ECG is used as a baseline in patients with no heart or blood problems to compare with other ECG's that are required to be taken monthly while receiving or after stopping taking Tasigna. Tasigna patients are warned that the drug causes QT prolongation also, an irregular heartbeat, that can cause sudden death. Tasigna patients have died from strokes and also have been forced to undergo amputations of the toes and feet. Tasigna Lawsuits for Amputation, Atherosclerosis, Peripheral Arterial Disease.

More Recent Tasigna Atherosclerosis Lawsuit News:

Lawyers for Tasigna Atherosclerosis Lawsuits

Attorneys handling Tasigna lawsuits for leukemia, non-Hodgkin lymphoma, and multiple myeloma offer free, no-obligation case review for individuals and families who believe they may have grounds to file a Tasigna lawsuit. Working on a contingency basis, these attorneys are committed to never charging legal fees unless they win compensation in your Tasigna lawsuit. The product liability litigators handling Roundup claims at the Onder Law Firm have a strong track record of success in representing families harmed by dangerous drugs and consumer products.